Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

C Stephen Foster, M.D.

Co-Author

This page shows the publications co-authored by C Foster and William Christen.
Connection Strength

0.799
  1. Infliximab for the treatment of refractory scleritis. Br J Ophthalmol. 2010 May; 94(5):579-83.
    View in: PubMed
    Score: 0.109
  2. Daclizumab for treatment of birdshot chorioretinopathy. Arch Ophthalmol. 2008 Feb; 126(2):186-91.
    View in: PubMed
    Score: 0.096
  3. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology. 2008 Aug; 115(8):1416-21, 1421.e1.
    View in: PubMed
    Score: 0.096
  4. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007 Jul; 125(7):895-900.
    View in: PubMed
    Score: 0.092
  5. Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology. 2007 Aug; 114(8):1574-1579.e1.
    View in: PubMed
    Score: 0.090
  6. Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm. 2006 Apr; 14(2):99-104.
    View in: PubMed
    Score: 0.084
  7. Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm. 2004 Sep; 12(3):193-201.
    View in: PubMed
    Score: 0.076
  8. Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis. Graefes Arch Clin Exp Ophthalmol. 2003 Dec; 241(12):1000-5.
    View in: PubMed
    Score: 0.072
  9. Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology. 2002 Aug; 109(8):1532-7.
    View in: PubMed
    Score: 0.066
  10. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol. 2004 Jun; 111(3):303-10.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.